- Report
- September 2023
- 120 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Report
- June 2023
- 200 Pages
Global
From €7223EUR$7,500USD£6,212GBP
- Report
- April 2024
- 185 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- January 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4767EUR$4,950USD£4,100GBP
- Report
- March 2018
- 179 Pages
Global
From €1324EUR$1,375USD£1,139GBP
€2648EUR$2,750USD£2,278GBP
- Report
- May 2023
- 260 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- January 2022
- 200 Pages
Global
From €7223EUR$7,500USD£6,212GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- August 2022
United States
From €1868EUR$1,940USD£1,607GBP
- Report
- August 2022
Global
From €761EUR$790USD£654GBP
- Report
- August 2021
Global
From €3842EUR$3,990USD£3,305GBP
- Report
- August 2021
Europe
From €3293EUR$3,420USD£2,833GBP
- Report
- February 2021
Global
From €2850EUR$2,960USD£2,452GBP
- Clinical Trials
- January 2020
- 318 Pages
Global
From €2408EUR$2,500USD£2,071GBP
- Report
- August 2022
- 376 Pages
Global
From €2408EUR$2,500USD£2,071GBP
- Report
- June 2022
- 65 Pages
Global
From €4810EUR$4,995USD£4,137GBP
The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more